What is CE&IC?
Established in 1984, CE&IC operates as a full-service cGMP engineering and design firm, catering specifically to the stringent requirements of pharmaceutical and biotechnology clients. The company provides a comprehensive suite of project design services, encompassing planning, construction assistance, commissioning, and qualification. Furthermore, CE&IC extends its expertise to consulting, offering services such as capacity utilization studies and risk assessments. With over three and a half decades of experience, CE&IC has cultivated a strong reputation for developing compliant, efficient, and cost-effective solutions for US FDA, EU, and global market regulations.
How much funding has CE&IC raised?
CE&IC has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for CE&IC?
The company's large-scale late-stage funding context suggests a phase of significant expansion or strategic acquisition. CE&IC's deep-rooted expertise in cGMP compliance and facility design for the life sciences positions it to capitalize on ongoing growth within the pharmaceutical and biotech industries. Future developments are likely to focus on scaling operations, enhancing technological capabilities, and potentially broadening its service offerings to meet evolving market demands and regulatory landscapes.
See full CE&IC company page
